In conclusion, melatonin was found to have potent protective roles in diabetic retinopathy, and the effects were mediated through the attenuation of inflammation by NF-κB inhibition and the prevention of decreased activity of antioxidant enzymes via the Akt-induced Nrf2 pathway. Here, NFKB1 is linked to diabetic retinopathy.